PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsPerflubutane
Perflubutane
Perflubutane is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
V: Various drug classes in atc
— V08: Contrast media
— V08D: Ultrasound contrast media
— V08DA: Ultrasound contrast media
— V08DA06: Perflubutane, phospholipid microspheres
HCPCS
No data
Clinical
Clinical Trials
64 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
UlcerD014456MPATH_579—2——3—5
Coronary artery diseaseD003324—I25.1——3115
Peptic ulcerD010437HP_0004398K27———3—3
HypertensionD006973EFO_0000537I10—111—3
Portal hypertensionD006975EFO_0000666K76.6—111—3
HemorrhageD006470MP_0001914R58———2—2
Liver diseasesD008107HP_0002910K70-K77——11—2
Rectal diseasesD012002—————1—1
AnesthesiaD000758—————1—1
OsteoporosisD010024HP_0000939M81.0———1—1
Show 7 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Liver neoplasmsD008113EFO_1001513C22.0——2—911
Hepatocellular carcinomaD006528—C22.0——1—78
Myocardial ischemiaD017202EFO_1001375I20-I251—3—26
Coronary diseaseD003327————3—14
Liver cirrhosisD008103EFO_0001422K74.0——1—23
Neoplasm metastasisD009362EFO_0009708———1—23
InfertilityD007246HP_0000789——11——1
NeoplasmsD009369—C80——1——1
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HyperplasiaD006965EFO_0000536—11——12
Breast neoplasmsD001943EFO_0003869C5011——12
Heart failureD006333HP_0001635I5011———2
Pancreatic ductal carcinomaD021441——11———1
Pancreatic neoplasmsD010190EFO_0003860C2511———1
AdenocarcinomaD000230——11———1
Congenital adrenal hyperplasiaD000312—E25.011———1
Addison diseaseD000224—E27.111———1
Adrenogenital syndromeD047808—E25.911———1
Adrenocortical hyperfunctionD000308EFO_1000797—11———1
Show 5 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
CarcinomaD002277—C80.01———67
Duodenal ulcerD004381EFO_0004607K262————2
Healthy volunteers/patients———2————2
Bone diseasesD001847—M89.91————1
Gastric emptyingD005746——1————1
Knee osteoarthritisD020370EFO_0004616M171————1
OsteoarthritisD010003EFO_0002506M15-M191————1
Esophageal neoplasmsD004938—C151————1
IschemiaD007511EFO_0000556—1————1
Skin neoplasmsD012878EFO_0004198C441————1
Show 8 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Vitamin b 12 deficiencyD014806EFO_0000734E53.8————33
UltrasonographyD014463——————33
Postoperative painD010149—G89.18————11
Glucose intoleranceD018149HP_0000833R73.03————11
ElectroretinographyD004596——————11
DiseaseD004194EFO_0000408R69————11
Neuromuscular blockadeD019148——————11
Colonic neoplasmsD003110—C18————11
Kidney neoplasmsD007680EFO_0003865C64————11
Focal nodular hyperplasiaD020518——————11
Show 14 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common namePerflubutane
INNperflubutane
Description
Perflubutane is a fluorocarbon that is butane in which all of the hydrogens have been replaced by fluorines. Microbubbles of preflubutane are used in the ultrasound contrast agent BR14. It has a role as an ultrasound contrast agent. It is a gas molecular entity, a fluorocarbon and a fluoroalkane.
Classification
Small molecule
Drug classblood substitutes and/or diagnostics (perfluorochemicals)
Image (chem structure or protein)Loading
Structure (InChI/SMILES or Protein Sequence)
FC(F)(F)C(F)(F)C(F)(F)C(F)(F)F
Identifiers
PDB—
CAS-ID355-25-9
RxCUI—
ChEMBL IDCHEMBL2104979
ChEBI ID—
PubChem CID9638
DrugBank—
UNII IDSE4TWR0K2C (ChemIDplus, GSRS)
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Plot placeholder
Mock data
Subscribe for the real data
Additional graphs summarizing 1,384 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
2 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use